immunity News and Research

RSS

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.

2 Aug 2022

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

Researchers found prior exposure to SARS-CoV-2 Omicron sub-variants BA.1/BA.2 reduced the risk of breakthrough infection by its sub-variant BA.5.

2 Aug 2022

The time has come for DIY mandates on covid

Here we are in the grip of yet another covid-19 surge, yet most people I see out and about are behaving as if the pandemic is over. And I live in Los Angeles County, whose public health department is arguably one of the most vigilant and proactive in the U.S.

2 Aug 2022

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

A recent study published in the Journal of Food Biochemistry discovered that peimine from Fritillaria might be a possible SARS-CoV-2 variant infection inhibitor.

2 Aug 2022

Study suggests possible benefit from melatonin in COVID-19

A new study discusses the utility of vitamin C and melatonin as potentially therapeutic and capable of preventing acute lung injury in COVID-19.

1 Aug 2022

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers in the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

1 Aug 2022

Researchers find decline in life expectancy among Native Americans due to COVID-19

Native Americans experienced disproportionately high rates of deaths from COVID-19 due to poverty, crowded housing, high rates of chronic disease, employment in frontline jobs, and limited access to quality health care.

1 Aug 2022

Würzburg scientists are working on the development of new drugs to combat monkeypox

Poxviruses pose a threat to humanity that should be taken seriously, as the current outbreak of monkeypox shows.

1 Aug 2022

Scientists report exceptional selection pressure on coronavirus host receptors in bats compared to other mammals

A new study examined how ACE2 and DPP4 has evolved using the bat genetic dataset as well as other mammal species.

1 Aug 2022

Routine periodic fasting associated with lower hospitalization risk in patients with COVID-19

The main objective of a new prospective observational cohort study was to evaluate whether periodic fasting is linked with severe COVID-19 symptoms.

1 Aug 2022

Study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic

Researchers assessed the pre-existing cross-protective immune responses against SARS-CoV-2 nucleocapsid protein and spike protein before the COVID-19 pandemic in individuals residing in North and South America, Europe and Africa in vitro and in vivo.

1 Aug 2022

What is the immunopathogenesis of pediatric COVID-19?

Researchers assessed the immunopathogenesis of COVID-19 infection in children.

1 Aug 2022

ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval

"Welcome to ViruStop!" Recently, ACROBiosystems officially announced the launch of a new brand, ViruStop. ViruStop is specifically designed for virus research and development, committing to accelerating the process of infectious diseases vaccine research, development and approval.

From ACROBiosystems 1 Aug 2022

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

Researchers identified that among healthy young adults, the development of SARS-CoV-2 triggered memory B cell and antibody reactions were equivalent following mildly symptomatic or asymptomatic infections.

29 Jul 2022

Vitamin A supplementation is missed by two in five children in India, analysis finds

Two in five eligible children in India are missing out on preventive vitamin A supplementation designed to ward off the health problems associated with deficiency of the vitamin, finds an analysis of representative survey data, published in the open access journal BMJ Global Health.

29 Jul 2022

immunity News and Research

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

The time has come for DIY mandates on covid

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

Study suggests possible benefit from melatonin in COVID-19

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

Researchers find decline in life expectancy among Native Americans due to COVID-19

Würzburg scientists are working on the development of new drugs to combat monkeypox

Scientists report exceptional selection pressure on coronavirus host receptors in bats compared to other mammals

Routine periodic fasting associated with lower hospitalization risk in patients with COVID-19

Study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic

What is the immunopathogenesis of pediatric COVID-19?

ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

Vitamin A supplementation is missed by two in five children in India, analysis finds

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

What the polio case in New York tells us about the end of polio

Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News